Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

AMLXAMLX
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in AMYLYX PHARMACEUTICALS INC

JPMORGAN CHASE & CO holds 1.9M shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $34.9M as of 2026-Q2. The position was increased (+1067.2% shares). AMLX represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$34.9M

Current Shares

1.9M

Total Value Change

+$34.7M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+1067.2%
$34.9M0.0%$17.96
47
2026-Q1
Increased
159,663
+139.9%
$2M0.0%$14.11
42
2025-Q4
Decreased
66,547
-7.2%
$803,8880.0%$12.00
0
2025-Q3
Decreased
71,688
-18.5%
$974,2380.0%$14.90
0
2025-Q2
Increased
87,989
+62.7%
$564,0090.0%$6.33
24
2025-Q1
Decreased
54,069
-2.8%
$191,4040.0%$3.66
0
2024-Q4
New
55,606
-
$210,1910.0%$3.84
35

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used